KDNY - Chinook Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KDNY is currently covered by 2 analysts with an average price target of $45.99. This is a potential upside of $5.6 (13.86%) from yesterday's end of day stock price of $40.39.

Chinook Therapeutics's activity chart (see below) currently has 50 price targets and 38 ratings on display. The stock rating distribution of KDNY is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.02% with an average time for these price targets to be met of 363.73 days.

Highest price target for KDNY is $40, Lowest price target is $39, average price target is $36.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 08-Aug-2023. First documented stock forecast 20-Apr-2015.

Currently out of the existing stock ratings of KDNY, 2 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$42

$1.61 (3.99%)

$36

1 years 11 months 12 days ago
(08-Aug-2023)

2/3 (66.67%)

$1.68 (4.17%)

460

Hold

$30

$-10.39 (-25.72%)

$30

1 years 11 months 19 days ago
(01-Aug-2023)

1/2 (50%)

$-10.29 (-25.54%)

189

Hold

$40

$-0.39 (-0.97%)

$40

2 years 29 days ago
(21-Jun-2023)

8/8 (100%)

$1.63 (4.25%)

253

Hold

$40

$-0.39 (-0.97%)

$32

2 years 1 months 6 days ago
(14-Jun-2023)

2/2 (100%)

$2.37 (6.30%)

500

Hold

$41

$0.61 (1.51%)

$43

2 years 1 months 7 days ago
(13-Jun-2023)

1/3 (33.33%)

$3.13 (8.27%)

350

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KDNY (Chinook Therapeutics) average time for price targets to be met?

On average it took 363.73 days on average for the stock forecasts to be realized with a an average price target met ratio 64.02

Which analyst has the current highest performing score on KDNY (Chinook Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on KDNY (Chinook Therapeutics)?

Joseph Pantginis has 32 price targets and 24 ratings on KDNY

Which analyst is the currently most bullish on KDNY (Chinook Therapeutics)?

Emma Nealon with highest potential upside - $6.18

Which analyst is the currently most reserved on KDNY (Chinook Therapeutics)?

Joseph Pantginis with lowest potential downside - -$21.64

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?